Alembic given FDA OK for generic Doryx

Doxycycline hyclate delayed-release tablets have a market value of roughly $10 million for the 12 months ending September 2021, according to IQVIA.

Sandra Levy

1/13/2022

Alembic has received the Food and Drug Administration's nod for doxycycline hyclate delayed-release tablets.

The product is the generic of Mayne's Doryx tablets.

[Read more: Alembic obtains FDA nod for 2 generics]

It is indicated to reduce the development of drug-resistant bacteria.

Doxycycline hyclate delayed-release tablets have a market value of roughly $10 million for the 12 months ending September 2021, according to IQVIA.

[Read more: Alembic debuts generic Zebeta]

FDA approves new indication for Novo Nordisk’s Ozempic

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease.

Betty Crocker debuts afternoon tea kits inspired by Netflix’s 'Bridgerton'

Betty Crocker collaborated with Netflix's “Bridgerton” to launch baking kits that include crème puffs, sponge cakes and scones.

Costco to raise hourly pay, reaches tentative agreement with union

Costco also is adding vacation time for new employees during their first year and giving workers with 30 years of employment an additional week of time off, per a CNN report.

Walgreens buyout talks reportedly unlikely to culminate in a deal

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York private-equity firm Sycamore Partners is “mostly dead.”

Justice Department files nationwide lawsuit against Walgreens

The lawsuit alleges Walgreens knowingly filled millions of prescriptions that lacked a legitimate medical purpose.